BOND-III 21.2201

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2018-12-20 for BOND-III 21.2201 manufactured by Leica Biosystems Melbourne Pty. Ltd.

Event Text Entries

[131145361] The following information was documented for onsite review of the slide from the breast core biopsy sample stained for er in the run 3469 commencing on (b)(6) 2018, using the automated slide stainer bond-iii serial number (b)(4): "estrogen slide has strong intensity and percentage (80%), normal ducts were present and stained, external positive and negative control tissues were placed on the slide and stained as expected. " the following information was documented for onsite review of the slide from the breast core biopsy sample, cut at the same time with the (b)(6) staining, stained for er in the run 4616 commencing on (b)(6) 2018, using the automated slide stainer bond-iii serial number (b)(4): "estrogen is negative, normal ducts positive staining as expected. " the customer decided to re-cut slides to "avoid aging artifacts". The following information was documented for onsite review of the slide from the breast core biopsy sample, on a slide prepared just for oestrogen staining from the same biopsy, stained for er in the run 4645 commencing on (b)(6) 2018, using the automated slide stainer bond-iii serial number (b)(4): "estrogen negative, normal duct positive, external positive and negative control tissues (on the same slide) stained as expected. " the root cause of the er staining discrepancy between slides prepared from a breast core biopsy and stained in runs commencing on both (b)(6) 2018 using bond-iii automated slide stainer serial number (b)(4), as reported by the complainant, could not be attributed to the instrument from the information available. An additional er staining run, performed on (b)(6) 2018 on bond-iii automated slide stainer serial number (b)(4) using slide(s) re-cut from the original biopsy sample, showed the same staining as obtained from the run of (b)(6) 2018.
Patient Sequence No: 1, Text Type: N, H10


[131145362] On (b)(6) 2018, the complainant advised leica biosystems that the results of ihc staining of slides prepared from a breast core biopsy samples on (b)(6) 2018 using bond-lll automated slide stainer serial number (b)(4), were er 80%, pgr negative, ki67 70% and c-erbb2 3+. The patient subsequently attended another clinical centre for surgery and the result for er in the excised tissue and nodes was negative. Repeat ihc staining of the original biopsy sample by the complainant showed er 0% and her2 negative (1-2+). On (b)(6) 2018, the leica field support representative (fss) assigned to this event documented the following information: "patient was treated trastuzumab so we wait for fish results for confirmation. " as at 04 december 2018, leica biosystems has not received further information from the complainant.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number8020030-2018-00135
MDR Report Key8187998
Date Received2018-12-20
Date of Report2019-01-18
Date of Event2018-02-27
Date Mfgr Received2019-01-14
Device Manufacturer Date2017-01-11
Date Added to Maude2018-12-20
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS ADRIENNE HARDISTY
Manufacturer Street495 BLACKBURN ROAD
Manufacturer CityMOUNT WAVERLEY, VIC 3149
Manufacturer CountryAS
Manufacturer Postal3149
Manufacturer G1LEICA BIOSYSTEMS MELBOURNE PTY. LTD
Manufacturer Street495 BLACKBURN ROAD
Manufacturer CityMOUNT WAVERLEY, VIC 3149
Manufacturer CountryAS
Manufacturer Postal Code3149
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameBOND-III
Generic NameSLIDE STAINER
Product CodeKPA
Date Received2018-12-20
Model NumberBOND-III
Catalog Number21.2201
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerLEICA BIOSYSTEMS MELBOURNE PTY. LTD
Manufacturer Address495 BLACKBURN ROAD MOUNT WAVERLEY, VIC 3149 AS 3149


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2018-12-20

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.